Targeting SERPINB5 and MSLN for Pancreatic Cancer Therapy
Simple Summary Pancreatic cancer (PC) is a leading cause of cancer-related death, with no effective therapy for curing late-stage PC. Developing effective therapeutic strategies is an emergent unmet need. SERPINB5 is non-inhibitory toward serine proteases, and mesothelin (MSLN) is a tumor-associated antigen. SERPINB5 a...